Proteintech Expands Collaboration With Epigenetics Company Active Motif
September 8, 2021
ROSEMONT, Ill. -- Proteintech Group, an original manufacturer of antibodies, nanobodies and recombinant proteins, today announced that it has made a strategic investment in Active Motif, a life science tools company focused on bringing epigenetics into the translational and precision medicine segments. The companies did not disclose any financial details about the transaction. Active Motif [...]
September 8, 2021
CHICAGO -- Bringing an added level of confidence to the robust science that its assay offers, the bioMérieux, Inc. GENE-UP® NUTRAPLEX PRO™ multiplex pathogen detection assay has achieved the AOAC® Research Institute Performance Tested MethodsSM approval (PTM 082103). AOAC validation demonstrated statistical equiavalence to the U.S. Food and Drug (FDA) and U. S. Pharmacopeia (USP) reference methods for the detection [...]
September 8, 2021
NEW YORK -- Biotia, Inc., a company that delivers proprietary analytical software for infectious disease diagnostics, is experiencing rapid adoption by clinical researchers worldwide of its user-friendly software platform for the comprehensive surveillance and deeper insights into COVID-19 viral genetic variants. Biotia's COVID-DX software has been optimized for researchers sequencing COVID-19 clinical specimens and wastewater samples using the popular [...]
Euan O’Sullivan appointed CEO of LGC
September 8, 2021
Today, LGC announces that Euan O’Sullivan has been appointed Chief Executive Officer (CEO) of the organisation with immediate effect. Euan succeeds Tim Robinson, who will become Chairman of LGC having served as Chief Executive since May 2013. After joining LGC in 2007 as a Non-Executive Director, Euan served as Corporate Development Director from July 2010 [...]
September 8, 2021
Thermo Scientific TSQ Plus triple quadrupole mass spectrometer portfolio meets productivity demands through improved speed and sensitivity Caption: Thermo Scientific TSQ Plus Triple Quadrupole Mass Spectrometer (MS) Portfolio. SAN JOSE, Calif. – Lab managers, technology leaders and principal scientists in pharmaceutical, food and environmental laboratories can now benefit from accelerated throughput and improved sensitivity to [...]
BIO-TECHNE AND CARTERRA INITIATE A CLINICAL RESEARCH COLLABORATION FOR COVID-19 VARIANT ANALYSIS
September 8, 2021
Companies bring together cutting-edge technologies and expertise to advance the world's understanding of COVID-19 variants' mechanism of action MINNEAPOLIS and SALT LAKE CITY -- Bio-Techne, a leading supplier of high-quality and innovative tools for life science research, therapeutic manufacturing and clinical diagnostics and Carterra Inc., the world leader in high-throughput antibody screening and characterization, today [...]
September 8, 2021
Nashville site will deliver on strategy to enable reliable supply of critical materials used to produce new biologics and vaccines WALTHAM, Mass. -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced plans to establish a manufacturing facility in Nashville dedicated to the production of single-use technologies (SUT) products. This investment [...]
September 8, 2021
Delivers expanded heme-onc menu and the ability to analyze low-input samples SOUTH SAN FRANCISCO -- Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, today announced two key improvements to the core capabilities of its Tapestri Platform intended to expand its accessibility and utility in the area of hematologic oncology (heme-onc) research. These [...]
September 8, 2021
MOUNTAIN VIEW, Calif. -- DNAnexus, Inc., the leading cloud-based biomedical and data management platform for healthcare and life sciences, today announced the appointment of Asha S. Collins, PhD, to General Manager, Biobanks. Dr. Collins will be responsible for managing the UK Biobank project and supporting the company’s diverse global health research community. She will report [...]
September 8, 2021
Fremont, CA -- Alamar Biosciences, Inc., a precision proteomics company that brings both ultra-high sensitivity and massively parallel scale to proteomic analysis, announced today that it has closed its $80 million Series B financing round, bringing its total funding to $110 million. The Series B financing round was led by Sherpa Healthcare Partners and included [...]

